April 10, 2015 by Mark Hollmer
California’s EBR Systems said it raised $20 million for its wireless pacing device in a funding round joined by a former Medtronic executive and an unnamed “cardiovascular corporate strategic investor.”
The former Medtronic exec is Stephen Mahle, who once led the device giant’s cardiac rhythm managemnt division. Dr. Thomas Fogarty, whose Emergent Medical Partners is serving as lead investor, also participated, along with current backers Split Rock Partners, SV Life Sciences, Delphi Ventures and St. Paul Venture Capital, EBR said. Read more
April 13, 2015 by Mark Hollmer
Otsuka Holdings was joined by Sofinnova Partners in the round. ReCor said it’s met with the FDA to discuss its plans for the study of its Paradise RDN system, which would be undertaken at 20 to 25 clinical sites in the U.S. and Europe. Read more
April 13, 2015 by Brad Perriello
Leviticus Cardio said it landed a $1.5 million funding round for the wireless heart pump technology it’s readying for a 1st-in-human trial.
Petah Tikva, Israel-based Leviticus said its technology eliminates the need for the transcutaneous drivelines used to power left ventricular assist devices, instead using its coplanar energy transfer system to power the pumps, eliminating the source of infections that bedevil nearly half of all LVAD patients. Read more
April 15, 2015 by Brad Perriello
Ortho Kinematics said yesterday that it drummed up a $9.6 million Series C round for its vertebral motion analysis technology, its flagship product.
Investors in the round included Ortho Kinematics partner Medtronic, Texo Ventures, MB Venture Partners and other previous and new backers, Austin, Texas-based Ortho Kinematics said. Read more
April 16, 2015 by Val Kennedy
Clear Guide Medical won $1.5 million in funding from NIH to research the use of ultrasound imaging for needle insertions.
The 2-year SBIR Phase II award from the National Institutes of Health supports a goal of making the practice a more widespread tool used in a number of clinical specialties, the company said. Read more
At DeviceTalks Boston, Tyler Shultz will give attendees an inside look at Theranos and how he was able to sound the alarm after he realized the company was falling apart. Shultz will take attendees behind the story that everyone is talking about: the rise and fall of Elizabeth Holmes and her diagnostic company, Theranos.
Join Shultz and 1,000+ medical device professionals at the 8th annual DeviceTalks Boston.